Skip to content
Global Access Atlas

Market access pathways by country

Explore how an innovative medicine moves from approval to patient access.

Selected market

South Korea

MFDS approval does not guarantee reimbursement. HIRA assesses reimbursement suitability, the applicable NHIS price and contract procedures follow, and MOHW publishes the listing. CEA submission omission and RSA eligibility require separate checks.

MFDS
HIRA
HIRA
NHIS
MOHW
5 decision nodes17 cited sources

For education only — not regulatory, pricing or legal advice.

About the content and how to use it